Read this company snapshot
Daily valuation snapshot
Zhengye Biotechnology Holding Limited Class A Ordinary Shares: source evidence dated 2026-10-09.
- Daily close (USD)
- $1.73
- Market capitalization (USD)
- $81,987,080.48
- Price / earnings (TTM)
- Not reported
- Price / book
- 1.87
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research ZYBT in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research ZYBT in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing ZYBT with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $1.73 |
| Market capitalization (USD) | $81,987,080.48 |
| Price / earnings (TTM) | Not reported |
| Price / book | 1.87 |
No matching rows. Clear the filter to see all records.
Read ZYBT's valuation metrics
Company size
Zhengye Biotechnology Holding Limited Class A Ordinary Shares's recorded market capitalization is $81,987,080.48. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
ZYBT's recorded price-to-book ratio is 1.87. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Zhengye Biotechnology Holding Limited Class A Ordinary Shares with Aurora
Use the snapshot above to ask a specific question about ZYBT. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow ZYBT's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.